Bioequivalence and Bioavailability Forum • Draft FDA Guidance Dec 2013

Draft FDA Guidance Dec 2013 [Regulatives / Guidelines]

posted by pash413 – India, 2013-12-04 16:05 (4592 d 09:24 ago) – Posting: # 12001
Views: 24,440

Dear All
FDA has released draft Guidance on PK studies for ANDA submission

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM377465.pdf

Complete thread:

Draft FDA Guidance Dec 2013pash413 2013-12-04 15:05 [Regulatives / Guidelines]
- First impressions Helmut 2013-12-04 16:47
  - First impressions nasir 2014-02-14 06:47
- What is Bioequivalence in the US really? ElMaestro 2013-12-07 23:34
  - Site of action vs. systemic circulation Helmut 2013-12-08 02:05
- Draft FDA Guidance Dec 2013 drgunasakaran1 2013-12-08 08:39
  - Two-stage or RSABE Helmut 2013-12-08 13:59
    - Two-stage or RSABE ElMaestro 2013-12-08 14:17
      - Two-stage methods Helmut 2013-12-08 14:44
        
        Two-stage methods ElMaestro 2013-12-08 18:56
    - RSABE Lucas 2014-03-24 17:05
      - RSABE Helmut 2014-03-24 17:25
        
        RSABE Lucas 2014-03-25 13:33
        
        RSABE Helmut 2014-03-25 14:31
        
        RSABE Lucas 2014-03-26 15:19
        
        RSABE Helmut 2014-03-26 15:28
  - Draft FDA Guidance Dec 2013 jag009 2013-12-09 22:31
    - Draft FDA Guidance Dec 2013 kvgreddy06 2014-02-14 16:44
- End of consultation approaching‼ Helmut 2014-02-26 11:32
  - End of consultation approaching‼ wien-ui 2014-03-01 08:05
    - End of consultation approaching‼ Helmut 2014-03-01 20:09
      - End of consultation approaching‼ wien-ui 2014-03-04 10:53

Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
287 visitors (0 registered, 287 guests [including 38 identified bots]).
Forum time: 02:30 CEST (Europe/Vienna)

When you meet the Buddha, you kill him;
when you meet the patriarchs, you kill them. Wumen Huikai

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz